A new trading day began on Friday, with Verastem Inc (NASDAQ: VSTM) stock price up 19.93% from the previous day of trading, before settling in for the closing price of $5.62. VSTM’s price has ranged from $2.18 to $9.10 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 31.36% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 24.83%. With a float of $48.90 million, this company’s outstanding shares have now reached $61.52 million.
In an organization with 78 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 25.0%, operating margin of -546129.17%, and the pretax margin is -619550.0%.
Verastem Inc (VSTM) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Verastem Inc is 11.00%, while institutional ownership is 85.55%. The most recent insider transaction that took place on Aug 06 ’25, was worth 7,739. In this transaction President and CEO of this company sold 1,332 shares at a rate of $5.81, taking the stock ownership to the 442,507 shares. Before that another transaction happened on Jun 20 ’25, when Company’s President and CEO sold 17,808 for $5.13, making the entire transaction worth $91,355. This insider now owns 443,839 shares in total.
Verastem Inc (VSTM) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.88 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.63 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.83% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 36.55% during the next five years compared to 31.36% growth over the previous five years of trading.
Verastem Inc (NASDAQ: VSTM) Trading Performance Indicators
Here are Verastem Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.44. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 193.84.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.51, a number that is poised to hit -0.62 in the next quarter and is forecasted to reach -2.03 in one year’s time.
Technical Analysis of Verastem Inc (VSTM)
Let’s dig in a bit further. During the last 5-days, its volume was 2.06 million. That was better than the volume of 1.69 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 46.46%.
During the past 100 days, Verastem Inc’s (VSTM) raw stochastic average was set at 53.63%, which indicates a significant decrease from 93.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.52 in the past 14 days, which was lower than the 0.54 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.47, while its 200-day Moving Average is $5.58.
